Compare NPKI & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NPKI | CYRX |
|---|---|---|
| Founded | 1932 | 1999 |
| Country | United States | United States |
| Employees | N/A | 1100 |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 883.3M |
| IPO Year | 1995 | 2008 |
| Metric | NPKI | CYRX |
|---|---|---|
| Price | $9.44 | $17.26 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 9 |
| Target Price | ★ $20.33 | $19.78 |
| AVG Volume (30 Days) | 577.7K | ★ 659.7K |
| Earning Date | 10-29-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 126.16 | ★ 156.22 |
| EPS | ★ 0.26 | N/A |
| Revenue | ★ $747,763,000.00 | $176,177,000.00 |
| Revenue This Year | $15.38 | $10.95 |
| Revenue Next Year | $10.54 | $10.11 |
| P/E Ratio | $42.92 | ★ N/A |
| Revenue Growth | ★ 58.59 | N/A |
| 52 Week Low | $10.51 | $7.61 |
| 52 Week High | $16.50 | $18.88 |
| Indicator | NPKI | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 24.74 | 48.47 |
| Support Level | N/A | $14.55 |
| Resistance Level | $14.86 | $18.17 |
| Average True Range (ATR) | 0.44 | 0.73 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 38.22 | 42.71 |
NPK International Inc is a temporary worksite access solutions company that manufactures, sells, and rents recyclable composite matting products, along with a full suite of services, including planning, logistics, and site restoration. The company generates majority of revenue from the rental of recyclable composite matting systems, along with related site construction and services to customers in various markets including power transmission, oil and natural gas exploration and production, pipeline, renewable energy, petrochemical, construction and other industries within the United States and United Kingdom. It generates maximum revenue from United States.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.